IL22 and Alzheimer disease: As patients age, particularly in adolescents and adults, the immune response evolves, with an increase in IL-22 frequencies, a cytokine involved in the pathogenesis of AD, and a progressive involvement of the TH22, TH17, and TH1 pathways.